Rui Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rui Liu has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Yifeng Du
Shandong Provincial Hospital Affiliated to Shandong First Medical University
5 shared publications Lin Cong
Shandong Provincial Hospital, Shandong University, Jinan China
4 shared publications- Chengxuan Qiu
Aging Research Center, Department of Neurobiology, Care Sciences and Society Karolinska Institutet and Stockholm University Stockholm Sweden
3 shared publications Yongxiang Wang
Department of Neurology, Shandong Provincial Hospital Shandong University Jinan People's Republic of China
3 shared publicationsJuan Ren
Department of Neurology, Shandong Provincial Hospital Shandong University Jinan People's Republic of China
2 shared publicationsXiaoyan Liang
Department of Neurology, Shandong Provincial Hospital Shandong University Jinan People's Republic of China
2 shared publications
Latest Publications
- Open Access
- 24 January 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1342669
Hippocampal sparing in whole-brain radiotherapy for brain metastases: controversy, technology and the future
Whole-brain radiotherapy (WBRT) plays an irreplaceable role in the treatment of brain metastases (BMs), but cognitive decline after WBRT seriously affects patients’ quality of life. The development of cognitive dysfunction is closely related to hippocampal injury, but standardized criteria for predicting hippocampal injury and dose limits for hippocampal protection have not yet been developed. This review systematically reviews the clinical efficacy of hippocampal avoidance - WBRT (HA-WBRT), the controversy over dose limits, common methods and characteristics of hippocampal imaging and segmentation, differences in hippocampal protection by common radiotherapy (RT) techniques, and the application of artificial intelligence (AI) and radiomic techniques for hippocampal protection. In the future, the application of new techniques and methods can improve the consistency of hippocampal dose limit determination and the prediction of the occurrence of cognitive dysfunction in WBRT patients, avoiding the occurrence of cognitive dysfunction in patients and thus benefiting more patients with BMs.
- 24 January 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1342669
Open AccessHippocampal sparing in whole-brain radiotherapy for brain metastases: controversy, technology and the future
Whole-brain radiotherapy (WBRT) plays an irreplaceable role in the treatment of brain metastases (BMs), but cognitive decline after WBRT seriously affects patients’ quality of life. The development of cognitive dysfunction is closely related to hippocampal injury, but standardized criteria for predicting hippocampal injury and dose limits for hippocampal protection have not yet been developed. This review systematically reviews the clinical efficacy of hippocampal avoidance - WBRT (HA-WBRT), the controversy over dose limits, common methods and characteristics of hippocampal imaging and segmentation, differences in hippocampal protection by common radiotherapy (RT) techniques, and the application of artificial intelligence (AI) and radiomic techniques for hippocampal protection. In the future, the application of new techniques and methods can improve the consistency of hippocampal dose limit determination and the prediction of the occurrence of cognitive dysfunction in WBRT patients, avoiding the occurrence of cognitive dysfunction in patients and thus benefiting more patients with BMs.
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S4)
Prevalence and progression of subjective cognitive decline among rural Chinese older adults: A Population‐based follow‐up study
Background: Few studies have examined occurrence and progression of subjective cognitive decline (SCD) in rural China. We aimed to investigate the prevalence of SCD and explore factors associated with progression from SCD to cognitive impairment, no dementia (CIND) and Alzheimer’s disease (AD).Method: This community‐based study included 2488 cognitively unimpaired participants (age ≥65 years; 55.18% women; and 39.87% illiterate) in the Shandong Yanggu Study of Aging and Dementia who were examined at baseline (2014‐2015), of these, 1843 were followed in 2018. Demographic, epidemiological, clinical, and neuropsychological data were collected following a structured questionnaire. SCD was defined based on the Chinese version of the self‐rated Ascertain Dementia 8‐item Questionnaire (AD8) score. CIND and AD were diagnosed following the international criteria. Data were analyzed with the multivariate logistic regression models.Result: At baseline, 997 of the 2488 participants were defined to have SCD. The prevalence of SCD was 40.07%, and the prevalence was increased with age. Of the 1843 participants in the follow‐up examination in 2018, 189 were diagnosed with CIND and 58 with AD. Having SCD at baseline was significantly associated with the multi‐adjusted odds ratio (OR) of 1.55 (95% confidence interval = 1.14‐2.12) for incident CIND and 2.91 (1.56‐5.42) for incident AD. Of 745 participants with SCD at baseline, 97 progressed to CIND and 43 to AD during the average 3.79 years of follow‐up. Multivariable logistic regressions showed that the multi‐adjusted OR of incident CIND was 0.51 (0.26‐0.98) for high social support, whereas the multi‐adjusted OR of incident AD was 1.22 (1.14‐1.31) for older age (per 1‐year increment), 0.31 (0.11‐0.85) for high education, 2.77 (1.17‐6.57) for carrying the apolipoprotein E (APOE) ε4 allele, 0.29 (0.11‐0.75) for high social support, and 3.98 (1.37‐11.52) for mild depressive symptoms.Conclusion: SCD affects over 40% of rural‐dwelling older adults in China who are free of cognitive impairment. Older people with SCD are more likely to develop CIND and AD. Older age, illiteracy, APOE ε4 allele, low social support, and depressive symptoms are associated with accelerated progression from SCD to CIND or AD.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S4)
Open AccessPrevalence and progression of subjective cognitive decline among rural Chinese older adults: A Population‐based follow‐up study
Background: Few studies have examined occurrence and progression of subjective cognitive decline (SCD) in rural China. We aimed to investigate the prevalence of SCD and explore factors associated with progression from SCD to cognitive impairment, no dementia (CIND) and Alzheimer’s disease (AD).Method: This community‐based study included 2488 cognitively unimpaired participants (age ≥65 years; 55.18% women; and 39.87% illiterate) in the Shandong Yanggu Study of Aging and Dementia who were examined at baseline (2014‐2015), of these, 1843 were followed in 2018. Demographic, epidemiological, clinical, and neuropsychological data were collected following a structured questionnaire. SCD was defined based on the Chinese version of the self‐rated Ascertain Dementia 8‐item Questionnaire (AD8) score. CIND and AD were diagnosed following the international criteria. Data were analyzed with the multivariate logistic regression models.Result: At baseline, 997 of the 2488 participants were defined to have SCD. The prevalence of SCD was 40.07%, and the prevalence was increased with age. Of the 1843 participants in the follow‐up examination in 2018, 189 were diagnosed with CIND and 58 with AD. Having SCD at baseline was significantly associated with the multi‐adjusted odds ratio (OR) of 1.55 (95% confidence interval = 1.14‐2.12) for incident CIND and 2.91 (1.56‐5.42) for incident AD. Of 745 participants with SCD at baseline, 97 progressed to CIND and 43 to AD during the average 3.79 years of follow‐up. Multivariable logistic regressions showed that the multi‐adjusted OR of incident CIND was 0.51 (0.26‐0.98) for high social support, whereas the multi‐adjusted OR of incident AD was 1.22 (1.14‐1.31) for older age (per 1‐year increment), 0.31 (0.11‐0.85) for high education, 2.77 (1.17‐6.57) for carrying the apolipoprotein E (APOE) ε4 allele, 0.29 (0.11‐0.75) for high social support, and 3.98 (1.37‐11.52) for mild depressive symptoms.Conclusion: SCD affects over 40% of rural‐dwelling older adults in China who are free of cognitive impairment. Older people with SCD are more likely to develop CIND and AD. Older age, illiteracy, APOE ε4 allele, low social support, and depressive symptoms are associated with accelerated progression from SCD to CIND or AD.
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S2)
Ventricular electrocardiographic signatures associated with dementia and plasma Alzheimer’ s biomarkers in older adults: The MIND‐China study
Background: Cardiovascular risk factors and cardiovascular diseases (CVDs) have been linked with dementia. In addition, amyloid‐β (Aβ) is detected in the heart of patients with Alzheimer’s disease (AD). However, no population‐based studies have yet investigated the interrelationships of ventricular electrocardiographic (ECG) profiles (e.g., QT, JT, QRS intervals, and QRS axis angle) with dementia and plasma Alzheimer’s biomarkers.Method: This population‐based cross‐sectional study included 5110 participants (age ≥65 years; 57.2% women) from the baseline assessments of the multimodal interventions to delay dementia and disability in rural China (MIND‐China) in March‐September 2018; of these, 1273 had data on plasma Aβ42, Aβ40, total‐tau, and neurofilament light chain (NfL) that were measured using the single molecule array (SIMOA) technology. Ventricular ECG parameters included QT, QTc, JT, JTc, QRS intervals, and QRS axis angle. The DSM‐IV criteria were followed for the diagnosis of dementia, the NIA‐AA criteria for AD, and NINDS‐AIREN criteria for vascular dementia (VaD). Data were analyzed using the general linear models, multinomial logistic models, and restricted cubic splines.Result: Of the 5110 participants, 296 (5.79%) were diagnosed with dementia (192 with AD; 93 with VaD). The multivariable‐adjusted odds ratios (95% CI) of dementia associated with the quartiles of QT interval were 1.00 (reference), 1.66 (1.11‐2.50), 1.93 (1.25‐3.00), and 1.78 (1.10‐2.91), respectively. QTc, JT, and JTc intervals had analogous associations with dementia, and these ventricular ECG parameters were significantly associated with an increased likelihood of AD and VaD. The restricted cubic spline model suggested a significant association of QRS axis left deviation with VaD. In the plasma biomarker subsample, JT and JTc intervals were associated with multivariable‐adjusted β coefficients (95% CI) of ‐0.15 (‐0.27‐ ‐0.03) and ‐0.11 (‐0.20‐ ‐0.01), respectively, for Aβ42/Aβ40 ratio. The multivariable‐adjusted β coefficients (95% CI) of plasma NfL associated with QT, JT, and JTc intervals were 0.04 (0.01‐0.08), 0.06 (0.02‐0.09), and 0.04 (0.01‐0.07), respectively.Conclusion: Ventricular ECG signatures for dementia and plasma Alzheimer’s biomarkers in rural‐dwelling older adults are characterized by altered ventricular repolarization and depolarization. These results support the view that Aβ metabolism and neurodegeneration might be involved in the associations of ventricular ECG profiles with dementia.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S2)
Open AccessVentricular electrocardiographic signatures associated with dementia and plasma Alzheimer’ s biomarkers in older adults: The MIND‐China study
Background: Cardiovascular risk factors and cardiovascular diseases (CVDs) have been linked with dementia. In addition, amyloid‐β (Aβ) is detected in the heart of patients with Alzheimer’s disease (AD). However, no population‐based studies have yet investigated the interrelationships of ventricular electrocardiographic (ECG) profiles (e.g., QT, JT, QRS intervals, and QRS axis angle) with dementia and plasma Alzheimer’s biomarkers.Method: This population‐based cross‐sectional study included 5110 participants (age ≥65 years; 57.2% women) from the baseline assessments of the multimodal interventions to delay dementia and disability in rural China (MIND‐China) in March‐September 2018; of these, 1273 had data on plasma Aβ42, Aβ40, total‐tau, and neurofilament light chain (NfL) that were measured using the single molecule array (SIMOA) technology. Ventricular ECG parameters included QT, QTc, JT, JTc, QRS intervals, and QRS axis angle. The DSM‐IV criteria were followed for the diagnosis of dementia, the NIA‐AA criteria for AD, and NINDS‐AIREN criteria for vascular dementia (VaD). Data were analyzed using the general linear models, multinomial logistic models, and restricted cubic splines.Result: Of the 5110 participants, 296 (5.79%) were diagnosed with dementia (192 with AD; 93 with VaD). The multivariable‐adjusted odds ratios (95% CI) of dementia associated with the quartiles of QT interval were 1.00 (reference), 1.66 (1.11‐2.50), 1.93 (1.25‐3.00), and 1.78 (1.10‐2.91), respectively. QTc, JT, and JTc intervals had analogous associations with dementia, and these ventricular ECG parameters were significantly associated with an increased likelihood of AD and VaD. The restricted cubic spline model suggested a significant association of QRS axis left deviation with VaD. In the plasma biomarker subsample, JT and JTc intervals were associated with multivariable‐adjusted β coefficients (95% CI) of ‐0.15 (‐0.27‐ ‐0.03) and ‐0.11 (‐0.20‐ ‐0.01), respectively, for Aβ42/Aβ40 ratio. The multivariable‐adjusted β coefficients (95% CI) of plasma NfL associated with QT, JT, and JTc intervals were 0.04 (0.01‐0.08), 0.06 (0.02‐0.09), and 0.04 (0.01‐0.07), respectively.Conclusion: Ventricular ECG signatures for dementia and plasma Alzheimer’s biomarkers in rural‐dwelling older adults are characterized by altered ventricular repolarization and depolarization. These results support the view that Aβ metabolism and neurodegeneration might be involved in the associations of ventricular ECG profiles with dementia.
- 21 September 2022
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 70 (11) , 3138-3151
Associations of sleep timing and time in bed with dementia and cognitive decline among Chinese older adults: A cohort study
Background: The longitudinal associations of sleep timing and time in bed (TIB) with dementia and cognitive decline in older adults are unclear. Methods: This population‐based cohort study used data from 1982 participants who were aged ≥60 years, free of dementia, and living in rural communities in western Shandong, China. At the baseline (2014) and follow‐up (2018) examinations, sleep parameters were assessed using standard questionnaires. Cognitive function was measured using the Mini‐Mental State Examination (MMSE). Dementia was diagnosed following the DSM‐IV criteria, and the NIA‐AA criteria for Alzheimer disease (AD). Data were analyzed using restricted cubic splines, Cox proportional‐hazards models, and general linear models. Results: During the mean follow‐up of 3.7 years, dementia was diagnosed in 97 participants (68 with AD). Restricted cubic spline curves showed J‐shaped associations of sleep duration, TIB, and rise time with dementia risk, and a reverse J‐shaped association with mid‐sleep time. When sleep parameters were categorized into tertiles, the multivariable‐adjusted hazard ratio (HR) of incident dementia was 1.69 (95%CI 1.01–2.83) for baseline sleep duration >8 hours (vs. 7–8 h), 2.17 (1.22–3.87) for bedtime before 9 p.m. (vs. 10 p.m. or later), and 2.00 (1.23–3.24) for mid‐sleep time before 1 a.m. (vs. 1–1.5 a.m.). Early bedtime and mid‐sleep time were significantly associated with incident AD (HR range: 2.25–2.51; p < 0.05). Among individuals who were free of dementia at follow‐up, baseline long TIB, early bedtime and mid‐sleep time, early and late rise time, and prolonged TIB and advanced bedtime and mid‐sleep time from baseline to follow‐up were associated with a greater decline in MMSE score ( p < 0.05). These associations with cognitive decline were statistically evident mainly among men or participants who were aged 60–74 years. Conclusions: Long TIB and early sleep timing are associated with an increased risk of dementia, and the associations with greater cognitive decline are evident only among older people aged 60–74 years and men.
- 21 September 2022
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 70 (11) , 3138-3151
Associations of sleep timing and time in bed with dementia and cognitive decline among Chinese older adults: A cohort study
Background: The longitudinal associations of sleep timing and time in bed (TIB) with dementia and cognitive decline in older adults are unclear. Methods: This population‐based cohort study used data from 1982 participants who were aged ≥60 years, free of dementia, and living in rural communities in western Shandong, China. At the baseline (2014) and follow‐up (2018) examinations, sleep parameters were assessed using standard questionnaires. Cognitive function was measured using the Mini‐Mental State Examination (MMSE). Dementia was diagnosed following the DSM‐IV criteria, and the NIA‐AA criteria for Alzheimer disease (AD). Data were analyzed using restricted cubic splines, Cox proportional‐hazards models, and general linear models. Results: During the mean follow‐up of 3.7 years, dementia was diagnosed in 97 participants (68 with AD). Restricted cubic spline curves showed J‐shaped associations of sleep duration, TIB, and rise time with dementia risk, and a reverse J‐shaped association with mid‐sleep time. When sleep parameters were categorized into tertiles, the multivariable‐adjusted hazard ratio (HR) of incident dementia was 1.69 (95%CI 1.01–2.83) for baseline sleep duration >8 hours (vs. 7–8 h), 2.17 (1.22–3.87) for bedtime before 9 p.m. (vs. 10 p.m. or later), and 2.00 (1.23–3.24) for mid‐sleep time before 1 a.m. (vs. 1–1.5 a.m.). Early bedtime and mid‐sleep time were significantly associated with incident AD (HR range: 2.25–2.51; p < 0.05). Among individuals who were free of dementia at follow‐up, baseline long TIB, early bedtime and mid‐sleep time, early and late rise time, and prolonged TIB and advanced bedtime and mid‐sleep time from baseline to follow‐up were associated with a greater decline in MMSE score ( p < 0.05). These associations with cognitive decline were statistically evident mainly among men or participants who were aged 60–74 years. Conclusions: Long TIB and early sleep timing are associated with an increased risk of dementia, and the associations with greater cognitive decline are evident only among older people aged 60–74 years and men.
- Open Access
- 1 May 2022
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 17, 811-824
Self-Reported Sleep Characteristics Associated with Cardiovascular Disease Among Older Adults Living in Rural Eastern China: A Population-Based Study
Purpose: To investigate the cross-sectional associations of self-reported sleep characteristics with cardiovascular diseases (CVDs) and cardiovascular multimorbidity in older adults living in rural Eastern China. Patients and Methods: This population-based study included 4618 participants (age ≥ 65 years; 56.5% women) living in rural Eastern China. In March–September 2018, data were collected through interviews, clinical examinations, neuropsychological testing, and laboratory tests. Sleep parameters were assessed using the Pittsburgh Sleep Quality Index, Epworth Sleepiness Score, and Berlin questionnaire. Coronary heart disease (CHD), heart failure (HF), and stroke were defined according to in-person interviews, clinical and neurological examinations, and electrocardiogram examination. Data were analyzed using logistic regression and restricted cubic spline regression. Results: CHD was diagnosed in 991 participants, HF in 135 participants, and stroke in 696 participants. The multivariable-adjusted odds ratio (OR) of CHD was 1.27 (95% CI, 1.09– 1.49) for sleep duration ≤ 6 hours/night (vs > 6– 8 hours/night), 1.40 (1.20– 1.62) for poor sleep quality, and 1.22 (1.04– 1.43) for high risk for obstructive sleep apnea (OSA). The OR of HF was 2.16 (1.38– 3.39) for sleep duration > 8 hours/night, and 1.76 (1.22– 2.54) for high risk for OSA. In addition, the OR of stroke was 1.23 (1.04– 1.46) for poor sleep quality, 1.32 (1.01– 1.72) for excessive daytime sleepiness, and 1.42 (1.19– 1.70) for high risk for OSA. The associations of poor sleep with cardiovascular multimorbidity (≥ 2 CVDs) were stronger than that of sleep problems with a single CVD. Conclusion: Extreme sleep duration, high risk for OSA, and other sleep problems were associated with CVDs, especially cardiovascular multimorbidity.
- 1 May 2022
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 17, 811-824
Open AccessSelf-Reported Sleep Characteristics Associated with Cardiovascular Disease Among Older Adults Living in Rural Eastern China: A Population-Based Study
Purpose: To investigate the cross-sectional associations of self-reported sleep characteristics with cardiovascular diseases (CVDs) and cardiovascular multimorbidity in older adults living in rural Eastern China. Patients and Methods: This population-based study included 4618 participants (age ≥ 65 years; 56.5% women) living in rural Eastern China. In March–September 2018, data were collected through interviews, clinical examinations, neuropsychological testing, and laboratory tests. Sleep parameters were assessed using the Pittsburgh Sleep Quality Index, Epworth Sleepiness Score, and Berlin questionnaire. Coronary heart disease (CHD), heart failure (HF), and stroke were defined according to in-person interviews, clinical and neurological examinations, and electrocardiogram examination. Data were analyzed using logistic regression and restricted cubic spline regression. Results: CHD was diagnosed in 991 participants, HF in 135 participants, and stroke in 696 participants. The multivariable-adjusted odds ratio (OR) of CHD was 1.27 (95% CI, 1.09– 1.49) for sleep duration ≤ 6 hours/night (vs > 6– 8 hours/night), 1.40 (1.20– 1.62) for poor sleep quality, and 1.22 (1.04– 1.43) for high risk for obstructive sleep apnea (OSA). The OR of HF was 2.16 (1.38– 3.39) for sleep duration > 8 hours/night, and 1.76 (1.22– 2.54) for high risk for OSA. In addition, the OR of stroke was 1.23 (1.04– 1.46) for poor sleep quality, 1.32 (1.01– 1.72) for excessive daytime sleepiness, and 1.42 (1.19– 1.70) for high risk for OSA. The associations of poor sleep with cardiovascular multimorbidity (≥ 2 CVDs) were stronger than that of sleep problems with a single CVD. Conclusion: Extreme sleep duration, high risk for OSA, and other sleep problems were associated with CVDs, especially cardiovascular multimorbidity.
- 5 January 2022
- Published by Elsevier in Neurobiology of Aging
- Vol. 113, 143-151
Association and interaction of TOMM40 and PVRL2 with plasma amyloid-β and Alzheimer's disease among Chinese older adults: a population-based study
- 5 January 2022
- Published by Elsevier in Neurobiology of Aging
- Vol. 113, 143-151
Association and interaction of TOMM40 and PVRL2 with plasma amyloid-β and Alzheimer's disease among Chinese older adults: a population-based study
- Open Access
- 17 December 2021
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12, 782453
A Common R219K Variant of ATP-Binding Cassette Transporter A1 Gene Alters Atherometabolic Traits in Pregnant Women With Gestational Diabetes Mellitus
Background: ATP-binding cassette transporter A1 (ABCA1) has important roles in high-density lipoprotein (HDL) metabolism and reverse cholesterol transport, and is implicated in lipid-related disorders. Genetic variants are involved in the pathogenesis of gestational diabetes mellitus (GDM). The objective of this study was to investigate the association of rs2230806 (R219K), a single nucleotide polymorphism (SNP) in the lipid-related gene, with the risk of GDM and related traits.Methods: The SNP, rs2230806, was genotyped, and clinical and metabolic parameters were determined in 660 GDM patients and 1,097 control subjects. Genetic associations with related traits were also analyzed.Results: The genotype distributions were similar in GDM patients and normal controls. However, significant differences in the variables examined in the study subjects were noted across the three genotypes. The genotype at the rs2230806 polymorphism was significantly associated with HDL-cholesterol (HDL-C) levels and atherogenic index (AI) values in GDM patients and total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-C) levels in control subjects. Subgroup analysis showed that the polymorphism was associated with diastolic blood pressure, in addition to HDL-C levels and AI, in overweight/obese GDM patients, while it was associated with TC levels, AI, pre-pregnancy body mass index (BMI), and BMI at delivery in non-obese GDM patients. In addition, this polymorphism was associated with TC, LDL-C, and apoB levels in overweight/obese control subjects.Conclusions: The rs2230806 polymorphism in the ABCA1 gene was associated with variations in atherometabolic traits in GDM patients, with characteristics of BMI dependency, but not with GDM. Our findings highlight a link between related phenotypes in women with GDM and genetic factors.
- 17 December 2021
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12, 782453
Open AccessA Common R219K Variant of ATP-Binding Cassette Transporter A1 Gene Alters Atherometabolic Traits in Pregnant Women With Gestational Diabetes Mellitus
Background: ATP-binding cassette transporter A1 (ABCA1) has important roles in high-density lipoprotein (HDL) metabolism and reverse cholesterol transport, and is implicated in lipid-related disorders. Genetic variants are involved in the pathogenesis of gestational diabetes mellitus (GDM). The objective of this study was to investigate the association of rs2230806 (R219K), a single nucleotide polymorphism (SNP) in the lipid-related gene, with the risk of GDM and related traits.Methods: The SNP, rs2230806, was genotyped, and clinical and metabolic parameters were determined in 660 GDM patients and 1,097 control subjects. Genetic associations with related traits were also analyzed.Results: The genotype distributions were similar in GDM patients and normal controls. However, significant differences in the variables examined in the study subjects were noted across the three genotypes. The genotype at the rs2230806 polymorphism was significantly associated with HDL-cholesterol (HDL-C) levels and atherogenic index (AI) values in GDM patients and total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-C) levels in control subjects. Subgroup analysis showed that the polymorphism was associated with diastolic blood pressure, in addition to HDL-C levels and AI, in overweight/obese GDM patients, while it was associated with TC levels, AI, pre-pregnancy body mass index (BMI), and BMI at delivery in non-obese GDM patients. In addition, this polymorphism was associated with TC, LDL-C, and apoB levels in overweight/obese control subjects.Conclusions: The rs2230806 polymorphism in the ABCA1 gene was associated with variations in atherometabolic traits in GDM patients, with characteristics of BMI dependency, but not with GDM. Our findings highlight a link between related phenotypes in women with GDM and genetic factors.